Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods-what's around the corner?

Authors:
Grahn A; Coleman JA; Eriksson Y; Gabrielsson S; Madsen JS and 8 more

Journal:
World J Urol

Publication Year: 2023

DOI:
10.1007/s00345-023-04597-4

PMCID:
PMC10693501

PMID:
37725130

View on PubMed View on PMC View Publisher
Journal Information

Full Title: World J Urol

Abbreviation: World J Urol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patie…
Lilleby W; Kishan A; Geinitz H. (2024) - Transparency Score: 3/6
Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis.
Krausewitz P; Borkowetz A; Ortner G and 4 more (2024) - Transparency Score: 3/6
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review.
Dornisch AM; Zhong AY; Poon DMC and 2 more (2024) - Transparency Score: 3/6
Follow-up of vascular-targeted photodynamic therapy in a real-world setting.
Borkowetz A; Kwe J; Boehm K and 5 more (2024) - Transparency Score: 3/6
Neurological sphincter deficiency: is there a place for artificial urinary sphincter?
Vrijens D; Kendall H; Hervé F. (2024) - Transparency Score: 1/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestGrahn: None. Eriksson: None. Gabrielsson: Scientific Advisory Board, Anjarium Biosciences and patent granted for Exosomes for targeting B-cells for therapy. Skov Madsen: None. Tham: None. Thomas: None. Uhlén: None. Vollmer: None. Zieger: None. Osther: Consultation for Olympus, speaker for Coloplast, Boston Scientific, Olympus. Brehmer: Consultation for Boston Scientific. Ethical approvalThis is a review article involving no studies on human participants and/or animals. Informed consent is not relevant. Conflict of interest Grahn: None. Eriksson: None. Gabrielsson: Scientific Advisory Board, Anjarium Biosciences and patent granted for Exosomes for targeting B-cells for therapy. Skov Madsen: None. Tham: None. Thomas: None. Uhlén: None. Vollmer: None. Zieger: None. Osther: Consultation for Olympus, speaker for Coloplast, Boston Scientific, Olympus. Brehmer: Consultation for Boston Scientific."

Evidence found in paper:

"Funding Open access funding provided by Karolinska Institute."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025